European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
Same-day discharge in endometrial cancer surgery: current evidence and future directions
Same-day discharge in endometrial cancer surgery: current evidence and future directions
DOI: 10.22514/ejgo.2026.001
Ovarian cancer think tank: the use of integrated artificial intelligence and computational biology in ovarian cancer diagnosis and treatment
Ovarian cancer think tank: the use of integrated artificial intelligence and computational biology in ovarian cancer diagnosis and treatment
DOI: 10.22514/ejgo.2026.002
The role of omentectomy in the surgical management of mucinous and serous borderline ovarian tumors
The role of omentectomy in the surgical management of mucinous and serous borderline ovarian tumors
DOI: 10.22514/ejgo.2026.003
Influence of fatigue, psychological distress, social support, and uncertainty appraisal on quality of life in post-treatment patients with gynecological cancer
Influence of fatigue, psychological distress, social support, and uncertainty appraisal on quality of life in post-treatment patients with gynecological cancer
DOI: 10.22514/ejgo.2026.005
Prognostic value of neutrophil-to-leukocyte ratio in surgical outcomes of endometrial cancer
Prognostic value of neutrophil-to-leukocyte ratio in surgical outcomes of endometrial cancer
DOI: 10.22514/ejgo.2026.006
Analysis of the value of the combined application of multiple ultrasound modalities in the early diagnosis of breast cancer
Analysis of the value of the combined application of multiple ultrasound modalities in the early diagnosis of breast cancer
DOI: 10.22514/ejgo.2026.007
Knockdown of NUAK2 promotes ferroptosis by regulating the mTOR/c-Myc signaling pathway to inhibit endometrial cancer cell progression
Knockdown of NUAK2 promotes ferroptosis by regulating the mTOR/c-Myc signaling pathway to inhibit endometrial cancer cell progression
DOI: 10.22514/ejgo.2026.009
Published Ahead of Print
Special Issues
Recent advances in gynecological oncology surgery
Keywords: Endometrial cancer; Ovarian cancer; Gynecology oncology; Surgery; IA; Cervical cancer; Vulvar cancer
Editor: Dr. Stefano Restaino, MD,Dr. Martina Arcieri, MD, PhD
Submission deadline: 31 August 2026
Quality of Life in Gynecologic Malignancies
Keywords: Quality of life; Palliative care; Symptom management
Editor: Lori Spoozak, MD
Submission deadline: 31 December 2024
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 October 2025
Current Update in the Treatment of Cervical Cancer
Keywords: Radical Hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2025
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.
